Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12610000885099
Ethics application status
Approved
Date submitted
15/10/2010
Date registered
19/10/2010
Date last updated
9/02/2011
Type of registration
Retrospectively registered

Titles & IDs
Public title
Ventilator circuit flow selection during neonatal assist control volume guarantee ventilation: A randomised crossover trial
Scientific title
Ventilator circuit flow selection during neonatal assist control volume guarantee ventilation: A randomised crossover trial
Secondary ID [1] 252878 0
None
Universal Trial Number (UTN)
Trial acronym
AC/VG Flow Study
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Neonatal ventilation 258409 0
Condition category
Condition code
Respiratory 258575 258575 0 0
Other respiratory disorders / diseases
Reproductive Health and Childbirth 258614 258614 0 0
Complications of newborn

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Ventilator circuit (bias) flow 4, 6 and 8 L/min will be compared in random order. The intervention periods (epochs) will last for 20 mins. Each epoch will be preceded by a 10 minute washout period. Infants will be ventilated using assist control volume guarantee mode with the Drager Babylog 8000plus ventilator throughout the study
Intervention code [1] 257405 0
Treatment: Devices
Comparator / control treatment
See description of interventions
Control group
Active

Outcomes
Primary outcome [1] 259421 0
Proportion of ventilator inflations with expired tidal volume within 90-110% of target tidal volume identified from the ventilator waveforms/trigger data
Timepoint [1] 259421 0
These data are measured continually. The outcome is defined as the number of inflations in range / total number of inflations over the epoch
Secondary outcome [1] 265969 0
Ventilator parameters determined from the ventilator data including:
Rate, mean airway pressure, peak inflating pressure
Timepoint [1] 265969 0
The data are measured continually over the epoch. Epoch averages will be compared
Secondary outcome [2] 266022 0
Measures of cardiorespiratory stability including:
FiO2, SpO2, TcCO2, HR and BP assessed using the ventilator data, Masimo Radical pulse oximeter, and Philips Intellivue series monitor with transcutaneous module
Timepoint [2] 266022 0
These data are recorded every minute. The change over the epoch will be measured (average data from last 2 mins of epoch minus average data from last 2 mins of run in period prior to epoch)

Eligibility
Key inclusion criteria
Stable ventilated infants, ventilated using assist control volume guarantee (AC/VG) for previous 24 hours.
Minimum age
24 Hours
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Ventilator changes in previous 4 hours, pH < 7.2, pCO2>80 mmHg, FiO2 > 0.8, acute pneumothoax/pulmonary interstitial emphysema, significant congenital abnormality, severe PVH, receiving muscle relaxants or morphine infusion > 20 ug/kg/hr

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Randomised crossover trial. Allocation of order of interventions using sequentially numbered opaque envelopes
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer generated random number sequence
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Crossover
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
3/10/2008
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
26
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 257843 0
Government body
Name [1] 257843 0
NMHRC
Country [1] 257843 0
Australia
Primary sponsor type
Hospital
Name
Royal Womens's Hospital
Address
Locked Bag 300
Cnr Grattan Street/Flemington Road
Parkville
Vic 3052
Country
Australia
Secondary sponsor category [1] 257050 0
None
Name [1] 257050 0
Address [1] 257050 0
Country [1] 257050 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 259879 0
The Royal Womens Hospital Research and Ethics Committees
Ethics committee address [1] 259879 0
Ethics committee country [1] 259879 0
Australia
Date submitted for ethics approval [1] 259879 0
29/11/2007
Approval date [1] 259879 0
10/01/2008
Ethics approval number [1] 259879 0
Project 07/33

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 31777 0
Address 31777 0
Country 31777 0
Phone 31777 0
Fax 31777 0
Email 31777 0
Contact person for public queries
Name 15024 0
Kevin Wheeler
Address 15024 0
Newborn Research
Royal Women's Hospital
Locked Bag 300
Cnr Grattan Street/Flemington Road
Parkville
Vic 3052
Country 15024 0
Australia
Phone 15024 0
+61 3 8345 2000
Fax 15024 0
Email 15024 0
kevin.wheeler@thewomens.org.au
Contact person for scientific queries
Name 5952 0
Kevin Wheeler
Address 5952 0
Newborn Research
Royal Women's Hospital
Locked Bag 300
Cnr Grattan Street/Flemington Road
Parkville
Vic 3052
Country 5952 0
Australia
Phone 5952 0
+61 3 8345 2000
Fax 5952 0
Email 5952 0
kevin.wheeler@thewomens.org.au

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.